Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT05620498

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and…

This is an Open Phase II Clinical Study of Tislelizumab Combined with Lenvatinib and GEMOX Versus Tislelizumab Combined with GEMOX in the Treatment of Locally A…

China60 participantsStarted 2022-09-08

Treatment: tislelizumab+lenvatinib+GMOX, tislelizumab+GEMOX